Connect with us

International

Life after logistics

You’ll have to forgive me, as this is going to be one of those in-between Actuator weeks. I finally took a couple of days off last week after working…

Published

on

You’ll have to forgive me, as this is going to be one of those in-between Actuator weeks. I finally took a couple of days off last week after working through the last few weekends, and today I’ve been rewarded with a throbbing migraine. Isn’t the human body magical? Either way, it’s an exciting week for those of you who like their robotics newsletter short and to the point.

First thing I need to address is that video game controller. I’m a person on the internet. I wholly understand why others on the internet latched on to the modified Logitech G F710 Wireless Gamepad. OceanGate Expeditions was charging passengers $250,000 a head for a ride to see the Titanic. That’s roughly 6,250 F710s.

A lot of folks reading about the tragedy zeroed in on that little tidbit. Surely, they speculated, a company careless enough to entrust human lives to a Bluetooth PC game controller was just setting itself up for failure. If you’re looking for a quick way to meme-dunk on a tragedy, you go with the controller.

No doubt everyone reading this knows better. As of this writing, it’s too early to point the finger at one thing. For now, I’d say Mark Harris’ piece on OceanGate is a great place to look if you’re attempting to unpack what went wrong here. Quoting:

David Lochridge was terminated in January 2018 after presenting a scathing quality control report on the vessel to OceanGate’s senior management, including founder and CEO Stockton Rush, who is on board the missing vessel.

According to a court filing by Lochridge, the preamble to his report read: “Now is the time to properly address items that may pose a safety risk to personnel. Verbal communication of the key items I have addressed in my attached document have been dismissed on several occasions, so I feel now I must make this report so there is an official record in place.”

The report detailed “numerous issues that posed serious safety concerns,” according to the filing. These included Lochridge’s worry that “visible flaws” in the carbon fiber supplied to OceanGate raised the risk of small flaws expanding into larger tears during “pressure cycling.” These are the huge pressure changes that the submersible would experience as it made its way to and from the deep ocean floor. He noted that a previously tested scale model of the hull had “prevalent flaws.”

Image Credits: Logitech

Now, again, I would certainly wait for official reports before feeling confident enough to declare anything online. I’m also not rushing to dunk on anyone involved in this bit of human tragedy. What I can say is finger pointing at the use of a gaming controller seems misguided. If you’ve spent time in and around robots, you understand this.

I have very vivid memories of visiting military-backed robotics firms more than a decade or so ago and being genuinely surprised to see wildly expensive systems programmed to work with Xbox and PlayStation controllers. Over the years, these systems have only become more common. These gaming accessories are familiar — most people coming up through the military or entering the robotics world have used them for extended periods over the course of their lives. They also work — decades of gaming development have seen to that.

In 2018, USA Today reported with some surprise that the USS Colorado, the Navy’s 377-foot sub, was utilizing Xbox controllers. It noted at the time:

The Colorado is the first attack submarine where sailors use an Xbox controller to maneuver the photonics masts, which replaced periscopes, [Colorado commanding officer Cmdr. Reed] Koepp said. Other submarines have joysticks. Using commercial off-the-shelf technology saves money, and young sailors report to the submarine knowing how to use it, Koepp said.

Given the high-profile nature of this story, coupled with people focusing on the controller, I ultimately wonder whether companies and organizations will begin to back away from this longstanding practice. My guess is no — certainly not once the underlying causes are made clear. In the meantime, however, there are much bigger things to worry about in terms of the submarine story.

The second thing I wanted to discuss is also a plug. For the first time ever, TechCrunch is hosting a Hardware Stage at Disrupt. Hardware has always occupied a strange space on our site. We’ve never been a gadget blog — there are plenty of those (I’ve worked at a number myself). Instead, we’ve looked for unique ways to cover the category that fit with our broader mission.

For me, that’s meant two things. The first one is easy: hardware startups. It’s a great opportunity to see what’s just over the horizon for consumer electronics. The second one is ever evolving. It’s generally deeper tech and not consumer focused. It’s sometimes space, sometimes transportation and, more often than not, robotics.

Seeing as how I’m in charge of putting together the stage this year, that’s ultimately going to mean a lot of robots. We’ve got a few panels lined up that I’m excited to tell you about. Today, however, we’re starting with just one. This is probably something you’ve seen me write about quite a bit over the last few years. Manufacturing led the first major wave of automation, and now we’re in the midst of a logistics revolution. So, what’s next?

There are a lot of intriguing answers to the question, but for me, it keeps coming back to three major categories: healthcare, agtech and construction. All three are currently reeling from labor shortages, and they’re all relatively recession-proof in the sense that they’re, you know, necessary for life. And from where I sit, none seem anywhere near as far along as they should be.

If some venture capitalist firm was foolish enough to entrust me with their money, these are the three areas I would most heavily invest in at the moment (with food being another recession-proof necessity and therefore a close fourth). This is precisely why I’m excited that this is the first Disrupt panel I’m able to tell you about.

Single-topic panels are important, of course, but given Disrupt’s more general audience (versus one of our TC Sessions: Robotics events), I figured it would be fascinating for our audience to hear from leaders in a broader range of topics, discussing the future of robotics more broadly. And we couldn’t have asked for a better trio — Claire Delaunay, Tessa Lau and Andrea Thomaz. All three are super-smart veterans of TC events.

You likely know Claire Delaunay from her time at Nvidia’s very successful robotics push. These days, she’s investing in and involved with agtech firm Farm-ng as an advisory board member. Tessa Lau is the founder and CEO of robotic construction firm Dusty Robotics, and Andrea Thomaz is the co-founder and CEO of Diligent Robotics, whose Moxi robot you’ve probably seen if you’ve (unfortunately) been to a hospital recently.

Disrupt is being held in San Francisco September 19–21. More panels coming soon. Save up to $600 when you buy your pass now through August 11, and save 15% on top of that with promo code ACTUATOR. Learn more.

amazon re:mars logo

Image Credits: TechCrunch

Speaking of conferences, there will be no re:Mars this year. We kind of sensed this one coming, given the complete radio silence, coupled with major cost-cutting at Amazon. The company confirmed the lack of conference in a statement to TechCrunch:

AWS hosts hundreds of thousands of customers and partners every year at hundreds of events around the world. These events provide an invaluable opportunity to connect with our customers. Their time is precious and we take seriously the responsibility to make each event valuable for every attendee, whether that’s through developing new skills, identifying new solutions that will transform an organization, or building new connections that can advance a career. We consulted with customers and the community as always, and for 2023, decided to incorporate re:MARS topics — machine learning, automation, robotics, and space — into a well-funded lineup of existing AWS events.

All of the cloud stuff aside, I really enjoyed re:Mars last year and was hoping to go back — even if it meant Las Vegas in the summer. The event has been a nice showcase for Amazon Robotics’ industrial systems, as well as innovations from a range of startups aligned with the company to varying degrees. Last year also saw some expansion into its home robotics play on the heels of the Astro announcement.

I had an interesting conversation with Ken Washington at last year’s event, though the automotive veteran has since moved on from his role as the head of Amazon’s consumer robotics play. Earlier this month, he was named the CTO of medical technology firm Medtronic.

“This new leadership role will help Medtronic to harness the innovative spirit of our founders and ensure we are capitalizing on our scientific and technological knowledge to invent, innovate and disrupt the healthcare technology market of the future,” said the company’s CEO, Geoff Martha. “Dr. Washington will help Medtronic expand use of our technology platforms across our portfolio — including robotics, sensors, implantables and AI — improving our returns on investments in innovation and expanding our technological competitive advantage to drive durable growth.”

Roomba

Image Credits: Brian Heater

Some happier news for Amazon’s consumer robotics play. There’s finally been some movement on the iRobot deal after months of radio silence. We knew regulators were going to slow things down considerably due to legitimate privacy and potential antitrust concerns — and they’ve certainly delivered. The initial announcement of the deal celebrates its first birthday in August, and things have been slow going since.

There are a lot of governmental bodies with lots of concerns, but two months after announcing that it would be looking at the deal, the U.K.’s Competition and Markets Authority has given it the go ahead, stating that it “would not lead to competition concerns in the U.K.” The FTC and the European Commission are both looking at the deal, with the latter planning to announce a decision next month.

Image Credits: KaraKuri

This week, Karakuri announced that it’s calling it quits. The food robotics startup cited an inability to raise in its decision to close up shop.

“It’s with a very heavy heart that I have to report that our journey at Karakuri is coming to an end,” founder and CEO Barney Wragg said in a LinkedIn post. “For the past five years, we’ve developed and deployed robotics for the QSR industry. We’ve survived many challenges, including the pandemic and our bank going bust [on] us, but sadly we’ve been unable to find the funding we need to move to the next level.”

Mike Butcher seemed suitably impressed when he checked out the company’s tech in December 2020, noting, “Last week I witnessed for myself how a new kind of robot really could — as sci-fi has been telling us for many years — create and serve us food.” There’s still a huge future in food robots, of course, but much like Zume’s recent closure, promising startups can’t always stick the landing. That’s a truism across all industries. Good on Wragg for including a list of now-former employees looking for gigs. Check out that post if you’re hiring.

This week, Estonian Uber competitor Bolt announced a last-mile robotic delivery partnership with Starship Technologies. The partnership is still very early stages, with a pilot program set for Tallinn, Estonia.

“Bolt and Starship share very similar goals of promoting sustainability in local transport. In our case, we offer a convenient and on-demand autonomous delivery service, perfectly aligning with the mission of making cities more eco-friendly,” Starship CEO Alastair Westgarth said in a release.

DeepMind RoboCat

Image Credits: DeepMind

And following on the tail of Google’s Barkour project is DeepMind’s RoboCat, whose name arrives courtesy of the Gato AI model. “The project is designed to adapt AI problem solving to real world robotic systems,” research scientist Alex Lee tells TechCrunch. “Provided with a limited number of demonstrations for a new task, RoboCat can be fine-tuned to the new tasks and in turn self-generate more data to improve even further.”


Image Credits: Bryce Durbin/TechCrunch

Life after logistics by Brian Heater originally published on TechCrunch

Read More

Continue Reading

International

IVI starts technology transfer to Biological E. Limited to manufacture oral cholera vaccine for India and global markets

  Credit: IVI IVI will complete the technology transfer by 2025 Oral Cholera Vaccine to be manufactured by Biological E. Limited for India and international…

Published

on

 

Credit: IVI

  • IVI will complete the technology transfer by 2025
  • Oral Cholera Vaccine to be manufactured by Biological E. Limited for India and international markets

 

March 20, 2024, SEOUL, Republic of Korea and HYDERABAD, India — The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, today announced that it has commenced a technology transfer of simplified Oral Cholera Vaccine (OCV-S) to Biological E. Limited (BE), a leading India-based Vaccines and Pharmaceutical Company.

 

Following the signing of a technology license agreement in November last year, IVI has begun providing the technical information, know-how, and materials to produce OCV-S at BE facilities and will continue to support necessary clinical development and regulatory approvals. IVI and BE entered this partnership during an unprecedented surge of cholera outbreaks worldwide and aim to increase the volume of low-cost cholera vaccine in India as well as the global public market.

 

IVI will complete the technology transfer by 2025 and the oral cholera vaccine will be manufactured for India and international markets by Biological E. Limited.

 

Dr. Jerome Kim, Director General of IVI, said: “In an era of heightened risk of poverty-associated infectious diseases such as cholera, the world needs a sustainable source of high-quality, affordable vaccines and committed manufacturers to supply them. We are pleased to partner with Biological E., a company with a proven history of making life-saving vaccines accessible globally, to address this supply gap and protect communities from this deadly, though preventable, disease.”

 

Ms. Mahima Datla, Managing Director, Biological E. Limited, said: “We are glad to be in collaboration with IVI for the manufacture of simplified Oral Cholera Vaccine. Our efforts are aimed to not only combat the disease but to also be part of a sustained legacy of innovation, collaboration, and health stewardship. Together with IVI, we are happy to be shaping a healthier and more resilient future by making this vaccine accessible globally.”

 

This technology transfer and licensing agreement is the sixth of its kind for IVI, transferring such technology to manufacturers in India, the Republic of Korea, Bangladesh, and South Africa. All these partnerships have led to or seek to achieve, pre-qualification (PQ) from the World Health Organization, a designation that enables global agencies such as UNICEF to procure the vaccine for the global market. BE already has 9 vaccines with WHO PQ in its portfolio, and IVI and BE will pursue WHO PQ for OCV-S as well, following national licensure in India.

 

Dr. Julia Lynch, Director of IVI’s Cholera Program, said: “The cholera situation is dire, and the availability and use of oral cholera vaccine is an essential part of a multifaceted approach to cholera control and prevention, especially as outbreaks increase and the global vaccine supply remains strained. With more manufacturers like BE entering the market, the future supply situation looks strong. IVI remains committed to ensuring the availability of the oral cholera vaccine and to developing new and improved vaccines that are equally safe, effective, and affordable and made around the world, for the world.”

 

OCV-S is a simplified formulation of OCV with the potential to lower production costs while increasing production capacity for current and aspiring OCV manufacturers. IVI’s development of OCV-S and ongoing technology transfers are part of an institutional strategy to confront cholera with 3 main goals: 1) Ensure supply of OCV 2) Improve cholera vaccines 3) Support OCV use and introduction. The Bill & Melinda Gates Foundation has been supporting IVI’s cholera program since 2000 and is funding this latest technology transfer to BE.

 

###

 

About the International Vaccine Institute (IVI)

The International Vaccine Institute (IVI) is a non-profit international organization established in 1997 at the initiative of the United Nations Development Programme with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health.

IVI’s current portfolio includes vaccines at all stages of pre-clinical and clinical development for infectious diseases that disproportionately affect low- and middle-income countries, such as cholera, typhoid, chikungunya, shigella, salmonella, schistosomiasis, hepatitis E, HPV, COVID-19, and more. IVI developed the world’s first low-cost oral cholera vaccine, pre-qualified by the World Health Organization (WHO), and developed a new-generation typhoid conjugate vaccine that also achieved WHO prequalification in early 2024.

IVI is headquartered in Seoul, Republic of Korea with a Europe Regional Office in Sweden, an Africa Regional Office in Rwanda, a Country Office in Austria, and a Country and Project Office in Kenya. IVI additionally co-founded the Hong Kong Jockey Club Global Health Institute in Hong Kong and hosts Collaborating Centers in Ghana, Ethiopia, and Madagascar. 39 countries and the WHO are members of IVI, and the governments of the Republic of Korea, Sweden, India, Finland, and Thailand provide state funding. For more information, please visit https://www.ivi.int.

 

 

About Biological E. Limited

Biological E. Limited (BE), a Hyderabad-based Pharmaceuticals & Biologics Company founded in 1953, is the first private sector biological products company in India and the first pharmaceutical company in Southern India. BE develops, manufactures and supplies vaccines and therapeutics. BE supplies its vaccines to more than 130 countries and its therapeutic products are sold in India, the USA and Europe. BE currently has 8 WHO-prequalified vaccines and 10 USFDA approved Generic Injectables in its portfolio. Recently, BE has received Emergency Use Listing (EUL) from the WHO for CORBEVAX®, the COVID-19 vaccine. Recently, DCGI has approved BE’S 14-Valent Pneumococcal Conjugate vaccine.

In recent years, BE has embarked on new initiatives for organizational expansion such as developing specialty injectable products for global markets as a means to manufacture APIs sustainably and developing novel vaccines for the global market.

Please follow us on Facebook, LinkedIn and Twitter

 

 

MEDIA CONTACTS

IVI

Aerie Em, Global Communications & Advocacy Manager
+82 2 881 1386 | aerie.em@ivi.int

 

Biological E. Limited

K. Vijay Amruth Raj
Email: Vijay.Kammari@biologicale.com
www.biologicale.com/news


Read More

Continue Reading

International

Bolsonaro Indicted By Brazilian Police For Falsifying Covid-19 Vaccine Records

Bolsonaro Indicted By Brazilian Police For Falsifying Covid-19 Vaccine Records

Federal police in Brazil have indicted former President Jair…

Published

on

Bolsonaro Indicted By Brazilian Police For Falsifying Covid-19 Vaccine Records

Federal police in Brazil have indicted former President Jair Bolsonaro for falsifying his Covid-19 vaccine card in order to travel to the United States and elsewhere during the pandemic.

Federal prosecutors will review the indictment and decide whether to pursue the case - which would be the first time the former president has faced criminal charges.

According to the indictment, Bolsonaro ordered a top deputy to obtain falsified Covid-19 vaccine records of himself and his 13-year-old daughter in late 2022, right before he flew to Florida for a three-month stay following his election loss.

Brazilian police are also waiting to hear back from the US DOJ on whether Bolsonaro used said cards to enter the United States, which would open him up to further criminal charges, the NY Times reports.

Bolsonaro has repeatedly claimed not to have received the Covid-19 vaccine, but denies any involvement in a plan to falsify his vaccination records. A previous investigation by Brazil's comptroller general concluded that Bolsonaro's vaccination records were false.

The records show that Bolsonaro, a COVID-19 skeptic who publicly opposed the vaccine, received a dose of the immunizer in a public healthcare center in Sao Paulo in July 2021. [ZH: hilarious, Reuters calling the vaccine an 'immunizer.']

The investigation concluded, however, that the former president had left the city the previous day and didn't leave Brasilia until three days later, according to a statement.

The nurse listed in the records as having applied the vaccine on Bolsonaro denied doing so and was no longer working at the center. The listed vaccine lot was also not available on that date, the comptroller general's office said. -Reuters

"It's a selective investigation. I'm calm, I don't owe anything," Bolsonaro told Reuters. "The world knows that I didn't take the vaccine."

During the pandemic, Bolsonaro panned the vaccine - and instead insisted on alternative treatments such as Ivermectin, which has antiviral properties against Covid-19. For this, he was investigated by Brazil's congress, which recommended that the former president be charged with "crimes against humanity," among other things, for his actions during the pandemic.

In May, Brazilian police raided Bolsonaro's home, confiscating his cell phone and arresting one of his closest aides and two of his security cards in connection to the vaccine record investigation.

Brazil's electoral court ruled that Bolsonaro can't run for public office until 2030 after he suggested that the country's voting system was rigged. For that, he has to sit out the 2026 election.

Tyler Durden Tue, 03/19/2024 - 11:00

Read More

Continue Reading

International

This gambling tech stock is future-proofing the world’s casinos

Supported by the universal thrill of a quick payout and the need for leisure, gambling stocks make a compelling case for long-term returns.
The post This…

Published

on

Supported by the universal human thrill of a quick payout, and the need for leisure and entertainment to bring enjoyment to adult life, casinos will remain essential spaces for people to dream and play for the foreseeable future, making gambling stocks a prospective space to look for long-term returns.

According to Research and Markets, the global casino industry was valued at US$157.5 billion in 2022, and it will grow to US$224.1 billion by 2030 at a compound annual growth rate of 4.5 per cent. This trend includes:

Approximately 100 million gamblers in the United States, who generated US$66.5 billion in revenue in 2023, a 10 per cent gain from 2022, which itself was a record year A little fewer than 20 million gamblers in Canada, who generated about C$15 billion in revenue in 2023 A global addressable market of thousands of casinos, and more than 4.2 billion people who gamble at least once every year, according to a 2016 study by Casino.org

The main challenge with attracting these billions through casino doors is they sway heavily toward middle age. The mean age of U.S. casino visitors has hovered around 50 for the past decade, with a similar trend across the world, forcing casinos to attract younger, tech-savvy customers, many with less gambling experience, to continue growing profits for their stakeholders over the long term.

Investors seeking exposure to a leadership position in building the bridge between casinos and the next generation of gamblers should evaluate Jackpot Digital (TSXV:JJ). The Vancouver-based company is a manufacturer of dealerless electronic table games that deliver immersive experiences tailored to the digital age, while earning casinos attractive returns on investment.

The gambling technology stock benefits from no direct competition in the dealerless poker space, with orders spanning North America, Europe, Asia, Africa and the Caribbean, a long-established presence with major cruise ship brands, such as Carnival, Princess Cruises and Holland America, and a growing land-based presence with orders or ongoing installations across 12 U.S. states. Its highlight partnership to date is a master services agreement with Penn Entertainment, the country’s largest regional gaming operator with 43 properties across 20 states.

Jackpot Digital’s differentiated technology and well-rounded management team are at the heart of its success in landing several blue-chip casino gaming companies as customers.

Jackpot Blitz

The gambling technology stock’s flagship product, Jackpot Blitz, is a dealerless poker table featuring three of the world’s most popular variations – Texas Hold’ em, Omaha, and Five-Card-Omaha – brought to life through slick 4k graphics on a 75-inch touchscreen, and offered in three formats – pot-limit, no-limit and fixed-limit – designed to attract a diversity of revenue from casual to experienced players.

Spokesperson and NFL championship-winning coach Jimmy Johnson explains the benefits of the Jackpot Blitz. Source: Jackpot Digital.

The table also comes equipped with house-banked mini-games, including blackjack, baccarat and video poker, as well as side bets on the main poker game, such as Bet the Flop, all of which keep players engaged and entertained between, and even during, poker hands. The stunning Jackpot Blitz machine also offers multi-venue “Bad Beat” jackpot functionality, allowing casinos to offer a “Poker Powerball” with massive Jackpots, further enhancing the attractiveness of Jackpot Blitz to new players.

It’s by striking a balance between the needs of the modern gambler, and efficiency and profitability that in-person operators couldn’t hope to match – unless they ordered the machine for themselves – that Jackpot Digital has earned itself the top spot in dealerless poker.

Player benefits

When a veteran or novice gambler takes a seat at the Jackpot Blitz, his or her experience begins with an easy-to-use interface, laid out in a modern and stylish design, programmed to respond to hand gestures that bring real casino play into the digital age, including card bending and chip jingling.

Source: Jackpot Digital.

The table’s intuitive controls, combined with instant payouts and its dealerless nature, translate into faster game play, which maximizes playing time and player excitement, while minimizing human error and the intimidation new gamblers might feel about approaching an analog poker table. The gambling technology stock’s in-house development team is also constantly working on new games to keep content fresh, with a special focus on bringing international games and regional versions of poker to casino audiences in Asia, South America and the Indian subcontinent.

As hands are laid down and pots pile up, players can also track game stats in real time, which inform future strategy and enhance the thrill of the moment with an added element of competition.

Operator benefits

From an operator’s perspective, a floor of automated gaming tables can meaningfully and instantly reduce casino staff expenditures and management pain points, while avoiding wage inflation, labour shortages and supply costs.

The Blitz is no slouch on revenue either, dealing more hands per hour, resulting in higher revenue and higher profitability, which is further enhanced by onboard side bets and mini-games that can be played while players are engaged in a poker hand.

The Jackpot Blitz’s economics are attractive to operators thanks to its ability to accommodate non-stop play, while monetizing downtime through side games and bets. While a human dealer must spend time shuffling, interacting with players, and consulting with colleagues, the Jackpot Blitz can accept wagers 100 per cent of the time, making sure gamblers get the action they came for and operators see a return on their investment.

Source: Jackpot Digital.

Beyond gaming revenue, casinos are further incentivized to onboard the Jackpot Blitz because of its fully customizable advertising functions, including logos, card backs, chips and felt colors, all of which bolster casino culture and enable the pursuit of revenue from third-party advertising partners.

The Blitz ties its value proposition together by generating automatic reports – including demographics and consumer behaviour through a rewards card system – and plugging directly into most back-end management systems, saving casinos the hassle of manual tracking, while also minimizing tampering, money-laundering and theft through the use of isolated servers.

Whether it’s streamlining the player experience or putting automation at the service of operators’ bottom lines, Jackpot Digital’s flagship product is positioned to create value, and plenty of it.

Jackpot Digital’s path to profitability

After existing as an exclusively cruise-ship-based operation since 2015, Jackpot Digital suffered a steep decline in revenue during the COVID pandemic, falling from C$2.18 million in 2019 to C$0.42 million in 2021.

Management quickly pivoted in the face of uncertainty, redesigning the Blitz to execute on a land-based expansion strategy – backed by Gaming Labs International certification in fall 2023 – which is bringing about a successful turnaround after the re-emergence of the casino business. Revenue more than tripled to C$1.43 million in 2022, and reached C$1.57 million through three quarters of 2023, with the company expecting to ramp up significant recurring revenue after it installs several dozen machines currently in its backlog.

The Jackpot Blitz electronic gaming table in action. Source: Jackpot Digital.

The first installation of land-ready Jackpot Blitz machines is now completed at the Jackson Rancheria Casino in California, as the company announced today. The three-machine installation marks a new era of growth for the company, having announced 25 Blitz deals since November 2021 (slide 12), with many more across Canada and the United States in the works, in addition to a strong pipeline in Asia and Europe.

“Jackpot Digital could be a profitable company right now if it only focused on care and maintenance of the revenues it currently generates. But that’s not why we’re here,” Mathieu McDonald, Vice President of Corporate Development at Jackpot Digital, said in a recent interview with Stockhouse. “We intend to scale up to many multiples of the tables we have out right now, with the potential for up to 2,000 tables over the next three to five years.”

According to McDonald, the company is fielding three to five inquiries per week about the Blitz from casinos around the world that recognize the machines’ first-mover advantage in dealerless poker and potential expansion into other games in need of automation.

Jackpot Digital’s ambitious plan of action is supported by a management team of proven gambling, finance, advertising and legal professionals, many of which have been serving Jackpot stakeholders for more than two decades.

A long-tenured management team

The management team behind Jackpot Digital is led by Jake Kalpakian, who has served as president and chief executive officer since 1999, including under the gambling technology stock’s former incarnation as Las Vegas From Home.com Entertainment Inc. Kalpakian brings more than 30 years of experience managing small-cap publicly listed companies, granting him a steady hand when it comes to maneuvering through the volatility of the economic cycle.

Kalpakian’s efforts are supported by three directors whose well-rounded expertise positions Jackpot Digital for long-term sustainable growth:

Gregory T. McFarlane, a director at Jackpot Digital since 1999, previously ran an independent advertising firm and holds a degree in mathematics from the University of Toronto. McFarlane is also a co-founder of the popular Control Your Cash personal finance website. Chief financial officer Neil Spellman, a director at the company since 2002, boasts an almost two-decade track record as vice president at Wall Street firm Smith Barney, where he developed a multi-industry understanding of the journey to profitability. Finally, Alan Artunian, a director since 2017, currently serves as CEO of Nice Guy Holdings, a corporate and legal consulting company advising clients across a diversity of sectors.

Guided by a strategic management team, and benefiting from a macro-trend toward casino automation, Jackpot Digital is on course to ride a wave of millions of gamblers looking for an elegant, tech-informed alternative to traditional in-person play.

A multi-bagger opportunity

The Jackpot Digital opportunity sets up savvy investors who recognize the soundness of the company’s value proposition. The tremendous risk/reward value of Jackpot Digital gives investors the opportunity to ride the macro-trend toward casino automation, as deals for the Blitz keep pouring in, the company adds games to its portfolio, and the global casino industry adds hundreds of billions in revenue through this decade.

Join the discussion: Find out what everybody’s saying about this gambling technology stock on the Jackpot Digital Bullboard.

This is sponsored content issued on behalf of Jackpot Digital, please see full disclaimer here.

The post This gambling tech stock is future-proofing the world’s casinos appeared first on The Market Online Canada.

Read More

Continue Reading

Trending